Latest Form 4 insider transactions

Girish Chandran, CTO, SVP Engineering of Viasat Inc, received 45,000 shares of common stock on October 9, 2026.

Peng Lu, President of Pharvaris N.V., reported multiple transactions in common stock on October 11, 2026.

Joseph M Miller, Chief Financial Officer of Lb Pharmaceuticals Inc, received 200,000 shares of common stock on October 9, 2026.

Susan Gani Kozauer, Chief Medical Officer of Lb Pharmaceuticals Inc, received 200,000 shares of common stock on October 9, 2026.

Robert James Blair, SVP, General Counsel of Viasat Inc, received 75,000 shares of common stock on October 9, 2026.

Michael Graham O'Brien, CFO of ZoomInfo Technologies Inc., sold 5,000 shares of common stock on October 9, 2026 for $4.00 per share.

Kristy D Banas, Chief Human Resources Officer of Willis Towers Watson Plc, reported multiple transactions in common stock on October 9, 2026.

Justyn Russell Howard, Executive Chair, a Director and 10% owner of Sprout Social, Inc., sold 40,000 shares of common stock on October 9, 2026 for $11.02 per share.

Michael Houston Aderhold, a 10% owner of QumulusAI, Inc., reported a transaction in 15,000 shares of common stock on October 9, 2026.

Alexis Faber, Chief Operating Officer of Willis Towers Watson Plc, reported multiple transactions in common stock on October 9, 2026.

Peter J. Taylor, a Director of Edison International, sold 500 shares of common stock on October 12, 2026 for $55.56 per share.

Michael H Tardugno, Executive Chairman of Board and a Director of Imunon, Inc., received 7,800 shares of common stock on October 9, 2026.

Fred Faching Chang, a Director and 10% owner of Newegg Commerce, Inc., sold 7,164 shares of common stock on 2026-10-08-05:00.

Matthew Furman, General Counsel of Willis Towers Watson Plc, reported multiple transactions in common stock on October 9, 2026.

Kelly L Palumbo, SVP, Controller and CAO of CAMPBELL'S Co, received 16,161 shares of common stock on October 1, 2026.

Julie Jarecke Gebauer, Pres.-Health, Wealth & Career of Willis Towers Watson Plc, reported multiple transactions in common stock on October 9, 2026.

Stacy Lindborg, President and CEO and a Director of Imunon, Inc., received 2,977 shares of common stock on October 9, 2026.

Ryan Cohen, President, CEO and Chairman and a Director of GameStop Corp., purchased 844,130 shares of common stock on October 13, 2026.

Julius Genachowski, a Director of Mastercard Inc, sold 741 shares of common stock on October 9, 2026.

Sarah Kaplan Browne, Chief Medical Officer of MetaVia Inc., received 53,000 shares of common stock on October 12, 2026.

Karl Alexander Vollert, a Director of State Street Corp, received 784 shares of common stock on October 9, 2026.

Marc Boroditsky, Chief Revenue Officer of Nebius Group N.V., sold 7,000 shares of common stock on October 12, 2026 for $211.23 per share.

Melissa Nippert, SVP, Chief Transformation Ofcr of CAMPBELL'S Co, received 19,709 shares of common stock on October 1, 2026.

Carl Aaron Hess, Chief Executive Officer and a Director of Willis Towers Watson Plc, reported multiple transactions in common stock on October 9, 2026.

Quantumsphere Acquisition Corporation has entered into a definitive agreement to merge with Fortune Favor Technology Inc., a company specializing in medical cold-chain transportation solutions.

Phillip Goldstein, Secretary and a Director of Swiss Helvetia Fund, Inc., purchased 5,000 shares of common stock on October 1, 2026 for $5.73 per share.

Daniel Gazit, Chief Product Officer of Kornit Digital Ltd., sold 552 shares of common stock on October 9, 2026 for $19.01 per share.

Pierre Sargis Sayad, Chief Medical Officer of Fennec Pharmaceuticals Inc., received 3,846 shares of common stock on October 12, 2026.

Douglas Vincent Faller, Chief Medical Officer of Imunon, Inc., received 1,249 shares of common stock on October 9, 2026.

Hongfei Huang, Chief Financial Officer of Chagee Holdings Ltd., received 675,464 shares of common stock on October 12, 2026.